Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
Santos
L D
LD
UPRESA 2391 Faculté de Médecine Saint-Antoine.
Lacube
P
P
Latouche
S
S
Kac
G
G
Mayaud
C
C
Marteau
M
M
Poirot
J L
JL
Maury
E
E
Guillot
J
J
Roux
P
P
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D004271:DNA, Fungal / Q000235:genetics; D003622:Dapsone / Q000627:therapeutic use; D004094:Dihydropteroate Synthase / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D016533:Mycological Typing Techniques; D011010:Pneumocystis / Q000145:classification* / Q000201:enzymology / Q000235:genetics*; D011020:Pneumonia, Pneumocystis / Q000453:epidemiology* / Q000382:microbiology* / Q000517:prevention & control; D016133:Polymerase Chain Reaction; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004271:DNA, Fungal; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003622:Dapsone; D004094:Dihydropteroate Synthase